These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 33799476)
1. A Nation-Wide, Multi-Center Study on the Quality of Life of ALS Patients in Germany. Peseschkian T; Cordts I; Günther R; Stolte B; Zeller D; Schröter C; Weyen U; Regensburger M; Wolf J; Schneider I; Hermann A; Metelmann M; Kohl Z; Linker RA; Koch JC; Büchner B; Weiland U; Schönfelder E; Heinrich F; Osmanovic A; Klopstock T; Dorst J; Ludolph AC; Boentert M; Hagenacker T; Deschauer M; Lingor P; Petri S; Schreiber-Katz O Brain Sci; 2021 Mar; 11(3):. PubMed ID: 33799476 [TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life in amyotrophic lateral sclerosis using EQ-5D-5L. Wei QQ; Hou Y; Chen Y; Ou R; Cao B; Zhang L; Yang T; Shang H Health Qual Life Outcomes; 2021 Jul; 19(1):181. PubMed ID: 34284776 [TBL] [Abstract][Full Text] [Related]
4. Trends of quality of life changes in amyotrophic lateral sclerosis patients. Shamshiri H; Fatehi F; Abolfazli R; Harirchian MH; Sedighi B; Zamani B; Roudbari A; Razazian N; Khamseh F; Nafissi S J Neurol Sci; 2016 Sep; 368():35-40. PubMed ID: 27538598 [TBL] [Abstract][Full Text] [Related]
5. Validation of the Persian version of the 40-item amyotrophic lateral sclerosis assessment questionnaire. Shamshiri H; Eshraghian MR; Ameli N; Nafissi S Iran J Neurol; 2013; 12(3):102-5. PubMed ID: 24250914 [TBL] [Abstract][Full Text] [Related]
6. [Validity and clinical applicability of the Japanese version of amyotrophic lateral sclerosis--assessment questionnaire 40 (ALSAQ-40)]. Yamaguchi T; Ohbu S; Saito M; Ito Y; Moriwaka F; Tashiro K; Ohashi Y; Fukuhara S No To Shinkei; 2004 Jun; 56(6):483-94. PubMed ID: 15328837 [TBL] [Abstract][Full Text] [Related]
7. Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease. Moore A; Young CA; Hughes DA Value Health; 2018 Nov; 21(11):1322-1329. PubMed ID: 30442280 [TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life across disease stages in patients with amyotrophic lateral sclerosis: results from a real-world survey. Stenson K; Fecteau TE; O'Callaghan L; Bryden P; Mellor J; Wright J; Earl L; Thomas O; Iqbal H; Barlow S; Parvanta S J Neurol; 2024 May; 271(5):2390-2404. PubMed ID: 38200398 [TBL] [Abstract][Full Text] [Related]
9. Prospective study to evaluate quality of life in amyotrophic lateral sclerosis. Caballero-Eraso C; Carrera-Cueva C; de Benito Zorrero E; Lopez-Ramirez C; Marin-Romero S; Asensio-Cruz MI; Barrot-Cortes E; Jara-Palomares L Sci Rep; 2023 Jul; 13(1):12074. PubMed ID: 37495641 [TBL] [Abstract][Full Text] [Related]
10. Spanish adaptation of the Amyotrophic Lateral Sclerosis Questionnaire ALSAQ-40 for ALS patients. Salas T; Mora J; Esteban J; Rodríguez F; Díaz-Lobato S; Fajardo M Amyotroph Lateral Scler; 2008 Jun; 9(3):168-72. PubMed ID: 18574761 [TBL] [Abstract][Full Text] [Related]
11. Cognitive deficits have only limited influence on health-related quality of life in amyotrophic lateral sclerosis. Prell T; Witte OW; Gunkel A; Grosskreutz J Aging Ment Health; 2020 Dec; 24(12):1963-1967. PubMed ID: 31317778 [TBL] [Abstract][Full Text] [Related]
12. Modelling disease course in amyotrophic lateral Sclerosis: pseudo-longitudinal insights from cross-sectional health-related quality of life data. Prell T; Gaur N; Steinbach R; Witte OW; Grosskreutz J Health Qual Life Outcomes; 2020 May; 18(1):117. PubMed ID: 32357946 [TBL] [Abstract][Full Text] [Related]
13. Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving Gebrehiwet P; Meng L; Rudnicki SA; Sarocco P; Wei J; Wolff AA; Butzner M; Chiò A; Andrews JA; Genge A; Hughes DA; Jackson CE; Lechtzin N; Miller TM; Shefner JM J Med Econ; 2023; 26(1):488-493. PubMed ID: 36930042 [TBL] [Abstract][Full Text] [Related]
16. Relationship between quantitative strength and functional outcomes in the phase 2 FORTITUDE-ALS trial. Shefner JM; Jacobsen B; Kupfer S; Malik FI; Meng L; Wei J; Wolff AA; Rudnicki SA Amyotroph Lateral Scler Frontotemporal Degener; 2024 Feb; 25(1-2):162-169. PubMed ID: 37641579 [TBL] [Abstract][Full Text] [Related]
17. Quality of life and motor impairment in ALS: Italian validation of ALSAQ. Palmieri A; Sorarù G; Lombardi L; D'Ascenzo C; Baggio L; Ermani M; Pegoraro E; Angelini C Neurol Res; 2010 Feb; 32(1):32-40. PubMed ID: 20092693 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of quality of life and mood disorders in caregivers of patients with amyotrophic lateral sclerosis: A single-center cross-sectional study. Okhovat AA; Fatehi F; Rafiemehr M; Moradi K; Kiani-Mehr G; Nafissi S Curr J Neurol; 2020 Oct; 19(4):190-195. PubMed ID: 38011396 [No Abstract] [Full Text] [Related]
19. Pain-Related Factors and Their Impact on Quality of Life in Chinese Patients With Amyotrophic Lateral Sclerosis. An R; Wu Y; Li Y; Li X; Ai S; Xu Y; He C Front Neurosci; 2022; 16():897598. PubMed ID: 35924224 [TBL] [Abstract][Full Text] [Related]
20. Fatigue in Chinese Patients With Amyotrophic Lateral Sclerosis: Associated Factors and Impact on Quality of Life. An R; Li C; Li X; Wu Y; He X; Ai S; Xu Y; He C Front Neurol; 2022; 13():806577. PubMed ID: 35250816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]